NanoSphere Health Sciences Inc.
NSHSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $288 | $26 | $113 | $1,372 |
| - Cash | $2 | $9 | $55 | $131 |
| + Debt | $31 | $0 | $0 | $0 |
| Enterprise Value | $316 | $16 | $58 | $1,241 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $252 | -$12 | -$271 | -$341 |
| % Margin | – | – | – | – |
| Net Income | $0 | -$228 | -$282 | -$356 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.024 | -0.022 | -0.027 | -0.052 |
| % Growth | 209.9% | 19% | 47.1% | – |
| Operating Cash Flow | -$36 | -$54 | -$68 | -$65 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$36 | -$54 | -$68 | -$65 |